1-4 of 4
Jaime Sanz Caballer, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety Analysis of Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients (pts) with Steroid-Refractory (SR) Acute Graft-Vs-Host Disease (aGVHD) in the Randomized Phase 3 REACH2 Study

Nikolas Von Bubnoff, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Eva Maria Wagner, MD, Edouard Forcade, MD PhD, Jaime Sanz Caballer, MD PhD, Domenico Russo, MD, Giovanni Grillo, MD, Tsila Zuckerman, MD, Sinem Civriz Bozdag, MD, Francis A. Ayuk, Friedrich Stoelzel, PD, MD, Sung-Soo Yoon, MD PhD, Jose Valentín García Gutiérrez, MD PhD, David Ritchie, MD ChB, PhD FRACP, FRCPA, Claude-Eric Bulabois, MD, Marie Thérèse Rubio, MD PhD, Judith Xu, Juliane Morando, MD, Bruyère Mahuzier, Pharm D, Satish Mahadevaiah Chandraiah, Gérard Socié, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–42.
https://doi.org/10.1182/blood-2020-137603
Published: 2020
Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT

Bhagirathbhai Dholaria, MBBS, Myriam Labopin, MD, Jaime Sanz Caballer, MD PhD, Annalisa Ruggeri, MD, Jan J. Cornelissen, MD PhD, Hélène Labussière-Wallet, Didier Blaise, MD, Edouard Forcade, MD, Patrice Chevallier, MD PhD, Anna Grassi, MD, Ludmila S Zubarovskaya, MD PhD professor, Jurgen H.E. Kuball, MD PhD, Patrice Ceballos, MD PhD, Fabio Ciceri, MD, Bipin N. Savani, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-139362
Published: 2020
Journal Articles

Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT

Firoozeh Sahebi, Dirk-Jan Eikema, Linda Koster, Nicolaus Kröger, Ellen Meijer, Goda Choi, Montserrat Rovira, Yener Koc, Emanuele Angelucci, Didier Blaise, MD, Corrado Tarella, Andrew McDonald, Concepcion Herrera Arroyo, Noel Milpied, Luca Castagna, Friedrich Stoelzel, PD, MD, Jaime Sanz Caballer, MD PhD, Johanna Tischer, Fabio Ciceri, David Valcarcel, Luigi Rigacci, Patrick J Hayden, MD, Meral Beksac, MD, Ibrahim Yakoub-Agha, Stefan Schonland
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-137789
Published: 2020
Journal Articles

Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available Therapy (BAT) in the Randomized, Phase 3 REACH2 Study

Gérard Socié, MD PhD, Dietger Niederwieser, MD PhD, Nikolas Von Bubnoff, Mohamad Mohty, MD PhD, Jeffrey Szer, MBBS, Reuven Or, MD, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Eva Maria Wagner, MD, Edouard Forcade, MD PhD, Jaime Sanz Caballer, MD PhD, Domenico Russo, MD, Giovanni Grillo, MD, Tsila Zuckerman, MD, Sinem Civriz Bozdag, MD, David Ritchie, MD ChB, PhD FRACP, FRCPA, Shalini Chaturvedi, Anirudh Prahallad, PhD, Karen Sinclair, PhD, Celine Wilke, MD, Robert Zeiser, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-140403
Published: 2020